Código 901819 (Harmonized System 2012 by 6 digits)
2023: US$1.48B, Total Trade Exchange
2023: US$1.03B, International Sales
2023: US$457M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) was US$1.48B.
In 2023, the states with the most international sales in Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were Baja California (US$782M), Chihuahua (US$147M), Jalisco (US$85.6M), Estado de México (US$6.95M), and Sonora (US$1.69M).
The states with the most international purchases in 2023 were Baja California (US$225M), Ciudad de México (US$104M), Chihuahua (US$91.3M), Jalisco (US$15.4M), and Tamaulipas (US$9.52M).
In 2023, the main commercial destinations of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were United States (US$956M), Netherlands (US$33.1M), Saudi Arabia (US$17M), Japan (US$4.34M), and China (US$3.64M).
The main commercial origins of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) in 2023 were United States (US$140M), China (US$77.9M), Malaysia (US$61.6M), Israel (US$39.7M), and Germany (US$27.6M).
In the global context, the main exporting countries of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) in 2022 were United States (US$4.27B), Germany (US$2.14B), and Japan (US$1.7B). In the same year, the main importing countries of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were United States (US$4.74B), Germany (US$1.89B), and Netherlands (US$1.17B).
US$1.48B, Total Trade Exchange (2023)
In 2023, the total trade exchange of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) in Mexico (including international purchases and sales) was US$1.48B.
The visualizations show the net balance of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024
In November 2024, international sales of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were US$79.8M, while international purchases reached US$35M. The above results in a trade balance of US$44.8M.
2024-Q4: US$166M, International Sales
The visualization shows the quarterly concentration of international sales of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) at state level.
In the fourth quarter of 2024, international sales were US$166M, being the states with the most sales Baja California (US$126M), Chihuahua (US$21.6M), and Jalisco (US$15.6M).
Baja California: US$782M, State with the Most International Sales (2023)
United States: US$956M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were Baja California (US$782M), Chihuahua (US$147M), Jalisco (US$85.6M), Estado de México (US$6.95M), and Sonora (US$1.69M).
In 2023, the countries with the most international purchases from Mexico were United States (US$956M), Netherlands (US$33.1M), Saudi Arabia (US$17M), Japan (US$4.34M), and China (US$3.64M).
Baja California: US$225M, State with the Most International Purchases (2023)
United States: US$140M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were Baja California (US$225M), Ciudad de México (US$104M), Chihuahua (US$91.3M), Jalisco (US$15.4M), and Tamaulipas (US$9.52M).
The countries with the most international sales to Mexico in 2023 were United States (US$140M), China (US$77.9M), Malaysia (US$61.6M), Israel (US$39.7M), and Germany (US$27.6M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were United States (US$4.27B), Germany (US$2.14B), and Japan (US$1.7B). In the same year, the main importing countries for Apparatus for Functional Exploration or for Surveillance of Physiological Parameters (Exc. Electrocardiographs, Diagnostic Apparatus for Ultrasonic Exploration) were United States (US$4.74B), Germany (US$1.89B), and Netherlands (US$1.17B).